e-Therapeutics plc
Notice of Preliminary Results
e-Therapeutics plc (AIM: ETX), the drug discovery and development company, will be announcing its final results for the 12 month period ending 31st January 2011 on Monday 25th July 2011.
Professor Malcolm Young, CEO, Daniel Elger, CFO, and Stephen Self, Development Director, will be hosting a presentation for analysts at 9.30am on the morning of the results at the offices of College Hill, The Registry, Royal Mint Court, EC3N 4QN.
-Ends-
For more information, please contact:
e-Therapeutics plc
Malcolm Young
Tel: +44 (0) 191 233 1317
Daniel Elger
Tel: +44 (0) 7909 915 068
Panmure Gordon (UK) Limited
Andrew Burnett / Aubrey Powell
Tel: +44 (0) 20 7459 3600
College Hill
Melanie Toyne Sewell/Jayne Crook
Tel: +44 (0) 20 7457 2020
Email: e-therapeutics@collegehill.com